Haverford Financial Services’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-6,101
| Closed | -$307K | – | 79 |
|
|
2018
Q2 | $307K | Sell |
6,101
-1,765
| -22% | -$88.8K | 0.12% | 64 |
|
|
2018
Q1 | $384K | Sell |
7,866
-712
| -8% | -$34.8K | 0.15% | 56 |
|
|
2017
Q4 | $380K | Buy |
8,578
+4,103
| +92% | +$182K | 0.14% | 57 |
|
|
2017
Q3 | $227K | Hold |
4,475
| – | – | 0.09% | 73 |
|
|
2017
Q2 | $241K | Buy |
4,475
+12
| +0.3% | +$646 | 0.1% | 52 |
|
|
2017
Q1 | $235K | Buy |
+4,463
| New | +$235K | 0.1% | 54 |
|
|
2016
Q4 | – | Sell |
-4,474
| Closed | -$241K | – | 61 |
|
|
2016
Q3 | $241K | Sell |
4,474
-40
| -0.9% | -$2.16K | 0.1% | 54 |
|
|
2016
Q2 | $245K | Sell |
4,514
-35
| -0.8% | -$1.9K | 0.1% | 57 |
|
|
2016
Q1 | $231K | Buy |
+4,549
| New | +$231K | 0.1% | 57 |
|
|
2014
Q4 | – | Sell |
-4,418
| Closed | -$254K | – | 46 |
|
|
2014
Q3 | $254K | Buy |
4,418
+271
| +7% | +$15.6K | 0.11% | 45 |
|
|
2014
Q2 | $277K | Sell |
4,147
-643
| -13% | -$42.9K | 0.12% | 41 |
|
|
2014
Q1 | $320K | Sell |
4,790
-292
| -6% | -$19.5K | 0.15% | 34 |
|
|
2013
Q4 | $339K | Buy |
5,082
+24
| +0.5% | +$1.6K | 0.16% | 38 |
|
|
2013
Q3 | $317K | Buy |
+5,058
| New | +$317K | 0.17% | 34 |
|